Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Psychological Medicine|April 22, 2005
Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studiesHelene Verdoux, Rajaa Lagnaoui, Bernard Begaud
Pharmacoepidemiology and Drug Safety|June 19, 2003
Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindoleNicholas Moore, Gillian Hall, Miriam Sturkenboom, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Benzodiazepine utilization patterns in Alzheimer's disease patientsRajaa Lagnaoui, Nicholas Moore, Yola Moride, et al.
European Journal of Clinical Pharmacology|September 1, 2004
Patterns and correlates of benzodiazepine use in the French general populationRajaa Lagnaoui, Fanny Depont, Annie Fourrier, et al.
Schizophrenia Research|September 12, 2002
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patientsChristine Montout, Francoise Casadebaig, Rajaa Lagnaoui, et al.
Fundamental & Clinical Pharmacology|August 15, 2009
Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in FranceFanny Depont, Elke Hunsche, Abdelilah Abouelfath, et al.
Basic & Clinical Pharmacology & Toxicology|July 13, 2004
Comparison of patient questionnaires and plasma assays in intentional drug overdosesMarcelle-Diane Matsika, Marie Tournier, Rajaa Lagnaoui, et al.
Journal of Clinical Epidemiology|February 28, 2002
Benzodiazepine use and risk of dementia: a nested case-control studyRajaa Lagnaoui, Bernard Bégaud, Nicholas Moore, et al.
Therapie|June 22, 2007
How is norepinephrine used in intensive care? A field studySylvie Blazejewski, Nathalie Raymond, Rajaa Lagnaoui, et al.
Pageof 1